| 前收市價 | 2.9000 |
| 開市 | 3.3000 |
| 買盤 | 1.1000 |
| 賣出價 | 4.8000 |
| 拍板 | 30.00 |
| 到期日 | 2024-05-17 |
| 今日波幅 | 3.3000 - 3.3000 |
| 合同範圍 | 無 |
| 成交量 | |
| 未平倉合約 | 97 |
ZacksBiotech Stock Roundup: IRON, VERV Down on Study Updates, BMYs Drug News & More
Disc Medicine, Inc. (IRON) and Verve Therapeutics (VERV) fall on study updates.
ZacksDisc Medicine (IRON) Down on Mixed Results From AURORA Study
Disc Medicine's (IRON) shares lose after a phase II study of bitopertin in patients with erythropoietic protoporphyria does not achieve the key secondary endpoint.
Investor's Business DailyDisc Medicine Plummets After Placebo Effect Confounds Sunlight Sensitivity Study
Disc's light sensitivity drug succeeded in a test Monday, but a large placebo response confounded the results. The biotech stock plummeted.
